Redmile Group, LLC has filed 106 insider transactions across 5 companies since April 2023.
Most recent transaction: a sale of 196229 shares of ADC Therapeutics SA ($ADCT) on March 31, 2026.
Activity breakdown: 39 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | S | Common Stock | 196229 | $3.75 | 25,735,799.0000 | 136,446,534 | 0.76% | 0.14% |
| April 2, 2026 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | S | Common Stock | 2529491 | $3.28 | 22,932,028.0000 | 136,446,534 | 9.93% | 1.85% |
| April 2, 2026 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | S | Common Stock | 2634506 | $3.28 | 22,932,028.0000 | 136,446,534 | 10.30% | 1.93% |
| April 1, 2026 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | S | Common Stock | 162517 | $3.80 | 25,461,519.0000 | 136,446,534 | 0.63% | 0.12% |
| April 1, 2026 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | S | Common Stock | 169265 | $3.80 | 25,566,534.0000 | 136,446,534 | 0.66% | 0.12% |
| March 31, 2026 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | S | Common Stock | 188407 | $3.75 | 25,624,036.0000 | 136,446,534 | 0.73% | 0.14% |
| Oct. 27, 2025 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Pre-Funded Warrants | 3846153 | $3.90 | 7,692,306.0000 | 136,446,534 | 100.00% | 2.82% |
| Oct. 27, 2025 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Pre-Funded Warrants | 3846153 | $3.90 | 7,692,306.0000 | 136,446,534 | 100.00% | 2.82% |
| Aug. 25, 2025 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | A | Pre-Funded Warrants to Purchase Common Stock | 4097730 | $0.00 | 7,198,553.0000 | 50,758,290 | 132.15% | 8.07% |
| Aug. 25, 2025 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | A | Common Warrants to Purchase Common Stock | 4097730 | $0.00 | 4,097,730.0000 | 50,758,290 | 9999.99% | 8.07% |
| Aug. 14, 2025 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | D | Pre-Funded Warrants to Purchase Common Stock | 667666 | $0.00 | 0.0000 | 61,816,099 | 100.00% | 1.08% |
| Aug. 14, 2025 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | D | Common Stock | 2964843 | $0.00 | 0.0000 | 61,816,099 | 100.00% | 4.80% |
| Aug. 14, 2025 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | D | Non-Voting Common Stock | 7199325 | $0.00 | 0.0000 | 61,816,099 | 100.00% | 11.65% |
| July 14, 2025 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| June 30, 2025 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | A | Common Stock | 828 | $0.00 | 2,964,843.0000 | 60,514,546 | 0.03% | 0.00% |
| June 11, 2025 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Pre-Funded Warrants | 12465234 | $3.43 | 28,199,501.0000 | 97,159,966 | 79.22% | 12.83% |
| June 11, 2025 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Pre-Funded Warrants | 15734267 | $3.43 | 28,199,501.0000 | 97,159,966 | 126.23% | 16.19% |
| May 29, 2025 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 113,685,177 | 9999.99% | 0.05% |
| March 31, 2025 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | A | Common Stock | 828 | $0.00 | 2,964,015.0000 | 60,514,546 | 0.03% | 0.00% |
| Dec. 31, 2024 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | A | Common Stock | 1734 | $0.00 | 2,963,187.0000 | 60,434,161 | 0.06% | 0.00% |
| Dec. 20, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Class A Convertible Preferred Stock | 116261 | $8.40 | 2,638,825.0000 | 117,769,161 | 4.22% | 0.10% |
| Dec. 20, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Cash-settled Swaps | 56331 | $1.68 | 502,769.0000 | 117,769,161 | 10.08% | 0.05% |
| Dec. 20, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Common Stock | 1084936 | $1.68 | 11,743,010.0000 | 117,769,161 | 8.46% | 0.92% |
| Dec. 20, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Common Stock | 1084936 | $1.68 | 12,827,946.0000 | 117,769,161 | 9.24% | 0.92% |
| Dec. 20, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | S | Common Stock | 341633 | $1.68 | 12,486,313.0000 | 117,769,161 | 2.66% | 0.29% |
| Dec. 20, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | P | Common Stock | 397964 | $1.68 | 12,884,277.0000 | 117,769,161 | 3.19% | 0.34% |
| Dec. 20, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Class A Convertible Preferred Stock | 116261 | $8.40 | 2,755,086.0000 | 117,769,161 | 4.41% | 0.10% |
| Dec. 12, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | C | Class A Convertible Preferred Stock | 6022 | $0.00 | 2,755,086.0000 | 117,769,161 | 0.22% | 0.01% |
| Dec. 12, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | C | Common Stock | 30110 | $0.00 | 12,827,946.0000 | 117,769,161 | 0.24% | 0.03% |
| Dec. 11, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Common Shares, par value CHF 0.08 per share | 50000 | $2.28 | 28,762,443.0000 | 104,824,877 | 0.17% | 0.05% |
| Dec. 11, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Common Shares, par value CHF 0.08 per share | 50000 | $3.81 | 28,812,443.0000 | 104,824,877 | 0.17% | 0.05% |
| Dec. 11, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Common Shares, par value CHF 0.08 per share | 50000 | $2.28 | 28,762,443.0000 | 104,824,877 | 0.17% | 0.05% |
| Dec. 11, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Common Shares, par value CHF 0.08 per share | 50000 | $3.81 | 28,812,443.0000 | 104,824,877 | 0.17% | 0.05% |
| Dec. 4, 2024 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | S | Common Stock, par value $0.0001 per share | 133371 | $1.25 | 5,406,353.0000 | 50,833,538 | 2.41% | 0.26% |
| Dec. 4, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | J | Pre-Funded Warrants | 26656 | $2.07 | 14,297,102.0000 | 104,824,877 | 0.19% | 0.03% |
| Dec. 4, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | J | Pre-Funded Warrants | 26656 | $2.07 | 14,297,102.0000 | 104,824,877 | 0.19% | 0.03% |
| Dec. 4, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | J | Pre-Funded Warrants | 26656 | $2.07 | 14,270,446.0000 | 104,824,877 | 0.19% | 0.03% |
| Dec. 4, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | J | Common Shares, par value CHF 0.08 per share | 50672 | $2.07 | 28,612,443.0000 | 104,824,877 | 0.18% | 0.05% |
| Dec. 4, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | J | Common Shares, par value CHF 0.08 per share | 50672 | $2.07 | 28,561,771.0000 | 104,824,877 | 0.18% | 0.05% |
| Dec. 4, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | S | Common Shares, par value CHF 0.08 per share | 25352 | $2.07 | 28,612,443.0000 | 104,824,877 | 0.09% | 0.02% |
| Dec. 4, 2024 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | J | Common Stock, par value $0.0001 per share | 1026888 | $1.25 | 5,539,724.0000 | 50,833,538 | 22.75% | 2.02% |
| Dec. 4, 2024 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | J | Common Stock, par value $0.0001 per share | 1026888 | $1.25 | 4,512,836.0000 | 50,833,538 | 18.54% | 2.02% |
| Dec. 4, 2024 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | P | Common Stock, par value $0.0001 per share | 133371 | $1.25 | 5,539,724.0000 | 50,833,538 | 2.47% | 0.26% |
| Dec. 4, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | J | Common Shares, par value CHF 0.08 per share | 50672 | $2.07 | 28,612,443.0000 | 104,824,877 | 0.18% | 0.05% |
| Sept. 30, 2024 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | A | Common Stock | 1734 | $0.00 | 3,081,800.0000 | 60,434,161 | 0.06% | 0.00% |
| July 1, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Common Shares, par value CHF 0.08 per share | 400000 | $2.81 | 28,664,257.0000 | 81,712,166 | 1.42% | 0.49% |
| July 1, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Common Shares, par value CHF 0.08 per share | 400000 | $2.81 | 28,664,257.0000 | 81,712,166 | 1.42% | 0.49% |
| June 28, 2024 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | A | Common Stock | 1734 | $0.00 | 3,080,066.0000 | 52,311,958 | 0.06% | 0.00% |
| June 21, 2024 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 12, 2024 | Absci Corp | $ABSI | Redmile Group, LLC | Director | A | Common Stock | 8820 | $0.00 | 8,262,136.0000 | 0 | 0.11% | 0.00% |
| June 12, 2024 | Absci Corp | $ABSI | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 36274 | $0.00 | 36,274.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 98,411,162 | 9999.99% | 0.04% |
| May 8, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Pre-Funded Warrants | 6107181 | $4.81 | 14,270,446.0000 | 81,712,166 | 74.81% | 7.47% |
| May 8, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Pre-Funded Warrants | 8163265 | $4.81 | 14,270,446.0000 | 81,712,166 | 133.67% | 9.99% |
| March 29, 2024 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | A | Common Stock | 1734 | $0.00 | 3,078,332.0000 | 52,311,958 | 0.06% | 0.00% |
| March 28, 2024 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | J | Common Stock | 12464 | $0.00 | 3,076,598.0000 | 52,311,958 | 0.40% | 0.02% |
| March 28, 2024 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | J | Common Stock | 4425 | $0.00 | 5,615,489.0000 | 42,600,190 | 0.08% | 0.01% |
| March 21, 2024 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | A | Pre-Funded Warrants to Purchase Common Stock | 3636364 | $5.50 | 3,893,674.0000 | 98,411,162 | 1413.22% | 3.70% |
| March 12, 2024 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 29400 | $0.00 | 29,400.0000 | 52,311,958 | 9999.99% | 0.06% |
| March 1, 2024 | Absci Corp | $ABSI | Redmile Group, LLC | Director | P | Common Stock | 222222 | $4.50 | 8,253,316.0000 | 0 | 2.77% | 0.00% |
| Feb. 28, 2024 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | C | Common Stock | 113400 | $0.00 | 3,089,062.0000 | 52,311,958 | 3.81% | 0.22% |
| Feb. 28, 2024 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | C | Non-Voting Common Stock | 113400 | $0.00 | 7,199,325.0000 | 52,311,958 | 1.55% | 0.22% |
| Jan. 10, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 100000 | $0.00 | 111,159.0000 | 81,712,166 | 896.14% | 0.12% |
| Jan. 9, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 100000 | $0.00 | 111,159.0000 | 81,712,166 | 896.14% | 0.12% |
| Jan. 8, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 100000 | $0.00 | 111,159.0000 | 81,712,166 | 896.14% | 0.12% |
| Jan. 25, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 100000 | $0.00 | 111,159.0000 | 81,712,166 | 896.14% | 0.12% |
| Feb. 2, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 11159 | $0.00 | 118,749.0000 | 81,712,166 | 10.37% | 0.01% |
| Feb. 2, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 144517 | $0.00 | 155,676.0000 | 81,712,166 | 1295.07% | 0.18% |
| Feb. 1, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 15867 | $0.00 | 123,457.0000 | 81,712,166 | 14.75% | 0.02% |
| Feb. 1, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 205483 | $0.00 | 216,642.0000 | 81,712,166 | 1841.41% | 0.25% |
| Feb. 1, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | J | Cash-settled Swaps | 19700 | $3.38 | 1,287,726.0000 | 81,712,166 | 1.51% | 0.02% |
| Jan. 31, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 150000 | $0.00 | 161,159.0000 | 81,712,166 | 1344.21% | 0.18% |
| Jan. 30, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 100000 | $0.00 | 111,159.0000 | 81,712,166 | 896.14% | 0.12% |
| Jan. 29, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 150000 | $0.00 | 161,159.0000 | 81,712,166 | 1344.21% | 0.18% |
| Jan. 26, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 100000 | $0.00 | 111,159.0000 | 81,712,166 | 896.14% | 0.12% |
| Feb. 7, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 107590 | $0.00 | 118,749.0000 | 81,712,166 | 964.15% | 0.13% |
| Jan. 24, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 50000 | $0.00 | 61,159.0000 | 81,712,166 | 448.07% | 0.06% |
| Jan. 16, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 53900 | $0.00 | 65,059.0000 | 81,712,166 | 483.02% | 0.07% |
| Jan. 12, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 93424 | $0.00 | 104,583.0000 | 81,712,166 | 837.21% | 0.11% |
| Jan. 11, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 100000 | $0.00 | 111,159.0000 | 81,712,166 | 896.14% | 0.12% |
| Jan. 5, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 50000 | $0.00 | 61,159.0000 | 81,712,166 | 448.07% | 0.06% |
| Jan. 4, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 28652 | $0.00 | 39,811.0000 | 81,712,166 | 256.76% | 0.04% |
| Jan. 3, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | J | Cash-settled Swaps | 59986 | $1.68 | 1,307,426.0000 | 81,712,166 | 4.39% | 0.07% |
| Jan. 3, 2024 | ADC Therapeutics SA | $ADCT | Redmile Group, LLC | TenPercentOwner | P | Cash-settled Swaps | 56900 | $0.00 | 68,059.0000 | 81,712,166 | 509.90% | 0.07% |
| Dec. 29, 2023 | IGM Biosciences, Inc. | $IGMS | Redmile Group, LLC | Director | A | Common Stock | 492 | $0.00 | 2,975,662.0000 | 41,543,954 | 0.02% | 0.00% |
| Dec. 26, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | P | Common Stock | 44630 | $3.72 | 13,180,388.0000 | 0 | 0.34% | 0.00% |
| Dec. 26, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Common Stock | 1655370 | $3.72 | 13,135,758.0000 | 0 | 14.42% | 0.00% |
| Dec. 26, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Common Stock | 1655370 | $3.72 | 13,135,758.0000 | 0 | 11.19% | 0.00% |
| Dec. 21, 2023 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | A | Pre-Funded Warrant to Purchase Common Stock | 3100823 | $0.00 | 3,100,823.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Absci Corp | $ABSI | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 53100 | $0.00 | 53,100.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Shattuck Labs, Inc. | $STTK | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 40258 | $0.00 | 40,258.0000 | 0 | 9999.99% | 0.00% |
| April 21, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | P | Common Stock | 256639 | $6.18 | 13,135,758.0000 | 0 | 1.99% | 0.00% |
| April 20, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | P | Common Stock | 20000 | $5.99 | 12,879,119.0000 | 0 | 0.16% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Class A Convertible Preferred Stock | 45752 | $29.20 | 2,761,108.0000 | 0 | 1.68% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Pre-Funded Warrants to Purchase Common Stock | 54960 | $5.84 | 257,310.0000 | 0 | 17.60% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Pre-Funded Warrants to Purchase Common Stock | 54960 | $5.84 | 257,310.0000 | 0 | 27.16% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Cash-settled Swaps | 550000 | $5.84 | 559,100.0000 | 0 | 49.59% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | P | Common Stock | 25700 | $6.00 | 12,859,119.0000 | 0 | 0.20% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Common Stock | 5492385 | $5.84 | 12,833,419.0000 | 0 | 74.82% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Common Stock | 5492385 | $5.84 | 12,833,419.0000 | 0 | 29.97% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | S | Common Stock | 302339 | $5.84 | 12,833,419.0000 | 0 | 2.30% | 0.00% |
| April 13, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | C | Common Stock | 167205 | $0.00 | 13,135,758.0000 | 0 | 1.29% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Cash-settled Swaps | 550000 | $5.84 | 559,100.0000 | 0 | 6043.96% | 0.00% |
| April 13, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | C | Class A Convertible Preferred Stock | 33441 | $0.00 | 2,761,108.0000 | 0 | 1.20% | 0.00% |
| April 14, 2023 | FATE THERAPEUTICS INC | $FATE | Redmile Group, LLC | Director | J | Class A Convertible Preferred Stock | 45752 | $29.20 | 2,761,108.0000 | 0 | 1.63% | 0.00% |